Departement
Klinische Forschung
Achtung: Diese Seite kann nur von Administratoren besucht werden, da Sie nicht freigeschalten wurde.
Zurück
Publications Yaldizli Özgür

Characteristics of improvements in balance control using vibro-tactile biofeedback of trunk sway for multiple sclerosis patients.

Allum JHJ; Rust HM; Lutz N; Schouenborg C; Fischer-Barnicol B; Haller V; Derfuss T; Kuhle J; Yaldizli Ö. Journal of the neurological sciences. 2021.

Comparative analysis of dimethyl fumarate and fingolimod in relapsing–remitting multiple sclerosis

Lorscheider J.; Benkert P.; Lienert C.; Hanni P.; Derfuss T.; Kuhle J.; Kappos L.; Yaldizli O.. Journal of Neurology. 2021.

Disability progression <i>in relapse-free</i> multiple sclerosis patients on fingolimod versus interferon-beta/glatiramer acetate.

von Wyl V; Benkert P; Moser A; Lorscheider J; Décard B; Hänni P; Lienert C; Kuhle J; Derfuss T; Kappos L; Yaldizli Ö. Multiple sclerosis (Houndmills, Basingstoke, England). 2021.

Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis.

Oechtering J; Schaedelin S; Benkert P; Müller S; Achtnichts L; Vehoff J; Disanto G; Findling O; Fischer-Barnicol B; Orleth A; Chan A; Pot C; Barakovic M; Rahmanzadeh R; Galbusera R; Heijnen I; Lalive PH; Wuerfel J; Subramaniam S; Aeschbacher S; Conen D; Naegelin Y; Maceski A; Meier S; Berger K; Wiendl H; Lincke T; Lieb J; Yaldizli Ö; Sinnecker T; Derfuss T; Regeniter A; Zecca C; Gobbi C; Kappos L; Granziera C; Leppert D; Kuhle J; Swiss Multiple Sclerosis Cohort Study.. Annals of neurology. 2021.

Syndrome of inappropriate antidiuretic hormone secretion and hypothalamic hypocortisolism in neuromyelitis optica.

Tsagkas C; Schäfer S; Baumgartner A; Müller J; Sinnecker T; Mehling M; van der Stouwe JG; Felder S; Panagiotou A; Potlukova E; Winzeler B; Scholz MC; Timper K; Blackham K; Nickel CH; Christ-Crain M; Bingisser R; Lyrer P; Kappos L; Yaldizli Ö. Lancet (London, England). 2021.

Improving Accuracy of Brainstem MRI Volumetry: Effects of Age and Sex, and Normalization Strategies.

Sander L; Horvath A; Pezold S; Andermatt S; Amann M; Sinnecker T; Wendebourg MJ; Kesenheimer E; Yaldizli Ö; Kappos L; Granziera C; Wuerfel J; Cattin P; Schlaeger R. Frontiers in Neuroscience. 2020.

Influence of age at disease onset on future relapses and disability progression in patients with multiple sclerosis on immunomodulatory treatment.

von Wyl V; Décard BF; Benkert P; Lorscheider J; Hänni P; Lienert C; Kuhle J; Derfuss T; Kappos L; Yaldizli Ö. European journal of neurology. 2020.

Muscle stiffness, gait instability, and liver cirrhosis in Wilson's disease.

Kronlage C; Hardmeier M; Bally S; Scholz MC; Bucher HC; Müller OK; Winterhalder C; Mongiat M; Müller J; Polymeris A; Weber M; Lausberg C; Kassi E; Kuhle J; Kappos L; Hermann W; Bernsmeier C; Yaldizli Ö. Lancet (London, England). 2020.

New and enlarging white matter lesions adjacent to the ventricle system and thalamic atrophy are independently associated with lateral ventricular enlargement in multiple sclerosis.

Sinnecker T; Ruberte E; Schädelin S; Canova V; Amann M; Naegelin Y; Penner IK; Müller J; Kuhle J; Décard B; Derfuss T; Kappos L; Granziera C; Wuerfel J; Magon S; Yaldizli Ö. Journal of Neurology. 2020.

Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study.

Jakimovski D; Zivadinov R; Ramanthan M; Hagemeier J; Weinstock-Guttman B; Tomic D; Kropshofer H; Fuchs TA; Barro C; Leppert D; Yaldizli Ö; Kuhle J; Benedict RH. Multiple sclerosis (Houndmills, Basingstoke, England). 2020.

A Framework for Estimating the Burden of Chronic Diseases: Design and Application in the Context of Multiple Sclerosis.

Kaufmann M; Puhan MA; Kuhle J; Yaldizli Ö; Magnusson T; Kamm CP; Calabrese P; von Wyl V. Frontiers in Neurology. 2019.

Balance Changes in Patients With Relapsing-Remitting Multiple Sclerosis: A Pilot Study Comparing the Dynamics of the Relapse and Remitting Phases.

Findling O; Rust H; Yaldizli Ö; Timmermans DPH; Scheltinga A; Allum JHJ. Frontiers in Neurology. 2018.

Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study.

Miller DH; Lublin FD; Sormani MP; Kappos L; Yaldizli Ö; Freedman MS; Cree BAC; Weiner HL; Lubetzki C; Hartung HP; Montalban X; Uitdehaag BMJ; MacManus DG; Yousry TA; Gandini Wheeler-Kingshott CAM; Li B; Putzki N; Merschhemke M; Häring DA; Wolinsky JS. Annals of Clinical and Translational Neurology. 2018.

Central Slab versus Whole Brain to Measure Brain Atrophy in Multiple Sclerosis.

Ruberte E; Sinnecker T; Amann M; Gaetano L; Naegelin Y; Penner IK; Kuhle J; Derfuss T; Kappos L; Granziera C; Wuerfel J; Yaldizli Ö. EUROPEAN NEUROLOGY. 2018.

Characterization of social cognition impairment in multiple sclerosis.

Neuhaus M; Bagutti S; Yaldizli Ö; Zwahlen D; Schaub S; Frey B; Fischer-Barnicol B; Burgunder JM; Martory MD; Pöttgen J; Annoni JM; Penner IK. European journal of neurology. 2018.

Comparative analysis of natalizumab versus fingolimod as second-line treatment in relapsing-remitting multiple sclerosis.

Lorscheider J; Benkert P; Lienert C; Hänni P; Derfuss T; Kuhle J; Kappos L; Yaldizli Ö. Multiple sclerosis (Houndmills, Basingstoke, England). 2018.

Response to the commentary of Yates RL and DeLuca GC on the study: HLA-DRB1*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis.

Yaldizli Ö; Sethi V; Pardini M; Tur C; Mok KY; Muhlert N; Liu Z; Samson RS; Wheeler-Kingshott CAM; Yousry TA; Houlden H; Hardy J; Miller DH; Chard DT. Multiple sclerosis and related disorders. 2018.

Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis.

Barro C; Benkert P; Disanto G; Tsagkas C; Amann M; Naegelin Y; Leppert D; Gobbi C; Granziera C; Yaldizli Ö; Michalak Z; Wuerfel J; Kappos L; Parmar K; Kuhle J. Brain : a journal of neurology. 2018.

Comparison between central and whole brain atrophy in multiple sclerosis measured by structural image evaluation using normalization of atrophy (SIENA)

Sinnecker, T.; Ruberte, E.; Amann, M.; Naegelin, Y.; Radue, E. W.; Penner, I. K.; Kuhle, J.; Derfuss, T.; Stippich, C.; Kappos, L.; Wuerfel, J.; Yaldizli, O.. Multiple sclerosis (Houndmills, Basingstoke, England). 2017.

Fingolimod vs. dimethyl fumarate in relapsing-remitting multiple sclerosis: propensity score matched comparison in a large observational data set

Lorscheider, J.; Benkert, P.; Lienert, C.; Hanni, P.; Schmid, J.; Derfuss, T.; Kuhle, J.; Kappos, L.; Yaldizli, O.. Multiple sclerosis (Houndmills, Basingstoke, England). 2017.

Neurostatus e-Scoring improves consistency of Expanded Disability Status Scale assessments: A proof of concept study.

D'Souza M; Yaldizli Ö; John R; Vogt DR; Papadopoulou A; Lucassen E; Menegola M; Andelova M; Dahlke F; Schnyder F; Kappos L. Multiple sclerosis (Houndmills, Basingstoke, England). 2017.

Serum neurofilament is associated with progression of brain atrophy and disability in early MS.

Kuhle J; Nourbakhsh B; Grant D; Morant S; Barro C; Yaldizli Ö; Pelletier D; Giovannoni G; Waubant E; Gnanapavan S. Neurology. 2017.

Serum neurofilament light chain correlates with disease activity and predicts clinical and MRI outcomes in MS

Barro, C.; Benkert, P.; Grobke, S.; Naegelin, Y.; Disanto, G.; Amann, M.; Magon, S.; Derfuss, T.; Yaldizli, O.; Parmar, K.; Wuerfel, J.; Kappos, L.; Kuhle, J.. Multiple sclerosis (Houndmills, Basingstoke, England). 2017.

Agomelatine Improves Apathy in Frontotemporal Dementia.

Callegari I; Mattei C; Benassi F; Krueger F; Grafman J; Yaldizli Ö; Sassos D; Massucco D; Scialò C; Nobili F; Serrati C; Amore M; Cocito L; Emberti Gialloreti L; Pardini M. Neurodegenerative Diseases. 2016.

Characteristics of lesional and extra-lesional cortical grey matter in relapsing-remitting and secondary progressive multiple sclerosis: A magnetisation transfer and diffusion tensor imaging study.

Yaldizli Ö; Pardini M; Sethi V; Muhlert N; Liu Z; Tozer DJ; Samson RS; Wheeler-Kingshott CA; Yousry TA; Miller DH; Chard DT. Multiple sclerosis (Houndmills, Basingstoke, England). 2016.

Cortical [11C]PBR28 PET Measures of Microglial Inflammation Explain Differences in Cognitive Performance of People with MS

Datta, Gourab; Battaglini, Marco; Scott, Gregory; Yaldizli, Ozgur; Santos-Ribeiro, Andre; Rabiner, Eugenii; Gunn, Roger; Owen, David; Malik, Omar; Ciccarelli, Olga; Nicholas, Richard; Langdon, Dawn; De Stefano, Nicola; Matthews, Paul. Neurology. 2016.

High sensitivity serum neurofilament-light chain measurements correlate with disease activity and disability in multiple sclerosis and are reduced after immunomodulatory treatment intervention.

Barro, C.; Derfuss, T.; Nagelin, Y.; Benkert, P.; Schadelin, S.; Yaldizli, O.; Achtnichts, L.; Nedeltchev, K.; Kamm, C. P.; Salmen, A.; Lalive, P. H.; Schluep, M.; Du Pasquier, R.; Muller, S.; Vehoff, J.; Norgren, N.; Zecca, C.; Disanto, G.; Gobbi, C.; Kappos, L.; Kuhle, J.. Multiple sclerosis (Houndmills, Basingstoke, England). 2016.

HLA-DRB*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis.

Yaldizli Ö; Sethi V; Pardini M; Tur C; Mok KY; Muhlert N; Liu Z; Samson RS; Wheeler-Kingshott CA; Yousry TA; Houlden H; Hardy J; Miller DH; Chard DT. Multiple sclerosis and related disorders. 2016.

Lateral Ventricle Volume change is associated with neurological and cognitive disability in multiple sclerosis: a 5-years follow-up study using an automated lateral ventricle segmentation algorithm

Ruberte, E.; Amann, M.; Naegelin, Y.; Penner, I. K.; Pardini, M.; Kuhle, J.; Derfuss, T.; Stippich, C.; Kappos, L.; Wuerfel, J.; Yaldizli, O.. Multiple sclerosis (Houndmills, Basingstoke, England). 2016.

Lower relapse rates with natalizumab as compared with fingolimod as second-line treatment in relapsing-remitting multiple sclerosis

Lienert, C.; Benkert, P.; Beer, S.; Hanni, P.; Pardini, M.; D'Souza, M.; Derfuss, T.; Kuhle, J.; Kappos, L.; Yaldizli, O.. Multiple sclerosis (Houndmills, Basingstoke, England). 2016.

Prevalence and cognitive underpinnings of isolated apathy in young healthy subjects.

Pardini M; Cordano C; Guida S; Grafman J; Krueger F; Sassos D; Massucco D; Abate L; Yaldizli Ö; Serrati C; Amore M; Mattei C; Cocito L; Emberti Gialloreti L. Journal of Affective Disorders. 2016.

Relationship of grey and white matter abnormalities with distance from the surface of the brain in multiple sclerosis.

Pardini M; Sudre CH; Prados F; Yaldizli Ö; Sethi V; Muhlert N; Samson RS; van de Pavert SH; Cardoso MJ; Ourselin S; Gandini Wheeler-Kingshott CA; Miller DH; Chard DT. Journal of neurology, neurosurgery, and psychiatry. 2016.

Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity.

Kuhle J; Barro C; Disanto G; Mathias A; Soneson C; Bonnier G; Yaldizli Ö; Regeniter A; Derfuss T; Canales M; Schluep M; Du Pasquier R; Krueger G; Granziera C. Multiple sclerosis (Houndmills, Basingstoke, England). 2016.

Spatial and temporal characteristics of magnetisation transfer ratio changes in different corticothalamic systems in multiple sclerosis

van de Pavert, S. H.; Pardini, M.; Eshaghi, A.; Prados, F.; Yaldizli, O.; Sethi, V.; Ourselin, S.; Wheeler-Kingshott, C. A. Gandini; Miller, D. H.; Ciccarelli, O.; Chard, D. T.. Multiple sclerosis (Houndmills, Basingstoke, England). 2016.

The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.

Yaldizli Ö; Penner IK; Yonekawa T; Naegelin Y; Kuhle J; Pardini M; Chard DT; Stippich C; Kira JI; Bendfeldt K; Amann M; Radue EW; Kappos L; Sprenger T. European journal of neurology. 2016.

The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography

Pardini, M; Botzkowski, D; Müller, S; Vehoff, J; Kuhle, J; Ruberte, E; Würfel, J; Gass, A; Valmaggia, C; Tettenborn, B; Putzki, N; Yaldizli, Ö. European journal of neurology. 2016.

The effect of vibrotactile biofeedback of trunk sway on balance control in multiple sclerosis.

van der Logt RP; Findling O; Rust H; Yaldizli O; Allum JH. Multiple sclerosis and related disorders. 2016.

The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options.

Disanto G; Benkert P; Lorscheider J; Mueller S; Vehoff J; Zecca C; Ramseier S; Achtnichts L; Findling O; Nedeltchev K; Radue EW; Sprenger T; Stippich C; Derfuss T; Louvion JF; Kamm CP; Mattle HP; Lotter C; Du Pasquier R; Schluep M; Pot C; Lalive PH; Yaldizli Ö; Gobbi C; Kappos L; Kuhle J; SMSC Scientific Board.. PLoS One. 2016.

Validation of an automated lateral ventricle delineation algorithm (ALVIN) in multiple sclerosis

Ruberte, E.; Amann, M.; Naegelin, Y.; Penner, I. K.; Pardini, M.; Kuhle, J.; Derfuss, T.; Stippich, C.; Kappos, L.; Wuerfel, J.; Yaldizli, O.. Multiple sclerosis (Houndmills, Basingstoke, England). 2016.

Association of Multiple Sclerosis Normal Appearing White Matter Abnormality with Periventricular Location and Secondary Progression

Chard,DT; Liu,Z; Pardini,M; Yaldizli,O; Sethi,V; Muhlert,N; Wheeler-Kingshott,CAM; Samson,RS; Miller,DH. . 2015.

Cervical cord area measurement using volumetric brain magnetic resonance imaging in multiple sclerosis.

Liu Z; Yaldizli Ö; Pardini M; Sethi V; Kearney H; Muhlert N; Wheeler-Kingshott C; Miller DH; Chard DT. Multiple sclerosis and related disorders. 2015.

Cervical cord area measurement using volumetric brain magnetic resonance imaging in multiple sclerosis.

Liu Z; Yaldizli Ö; Pardini M; Sethi V; Kearney H; Muhlert N; Wheeler-Kingshott C; Miller DH; Chard DT. Multiple sclerosis and related disorders. 2015.

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.

Kuhle J; Disanto G; Dobson R; Adiutori R; Bianchi L; Topping J; Bestwick JP; Meier UC; Marta M; Dalla Costa G; Runia T; Evdoshenko E; Lazareva N; Thouvenot E; Iaffaldano P; Direnzo V; Khademi M; Piehl F; Comabella M; Sombekke M; Killestein J; Hegen H; Rauch S; D'Alfonso S; Alvarez-Cermeño JC; Kleinová P; Horáková D; Roesler R; Lauda F; Llufriu S; Avsar T; Uygunoglu U; Altintas A; Saip S; Menge T; Rajda C; Bergamaschi R; Moll N; Khalil M; Marignier R; Dujmovic I; Larsson H; Malmestrom C; Scarpini E; Fenoglio C; Wergeland S; Laroni A; Annibali V; Romano S; Martínez AD; Carra A; Salvetti M; Uccelli A; Torkildsen Ø; Myhr KM; Galimberti D; Rejdak K; Lycke J; Frederiksen JL; Drulovic J; Confavreux C; Brassat D; Enzinger C; Fuchs S; Bosca I; Pelletier J; Picard C; Colombo E; Franciotta D; Derfuss T; Lindberg R; Yaldizli Ö; Vécsei L; Kieseier BC; Hartung HP; Villoslada P; Siva A; Saiz A; Tumani H; Havrdová E; Villar LM; Leone M; Barizzone N; Deisenhammer F; Teunissen C; Montalban X; Tintoré M; Olsson T; Trojano M; Lehmann S; Castelnovo G; Lapin S; Hintzen R; Kappos L; Furlan R; Martinelli V; Comi G; Ramagopalan SV; Giovannoni G. Multiple sclerosis (Houndmills, Basingstoke, England). 2015.

Diffusion Tensor Imaging Abnormalities in Multiple Sclerosis Cortical Lesions and Normal-Appearing Grey Matter and their Associations with Disability

Yaldizli,O; Pardini,M; Sethi,V; Muhlert,N; Liu,Z; Tozer,DJ; Samson,RS; Wheeler-Kingshott,CAM; Yousry,TA; Miller,DH; Chard,DT. . 2015.

Magnetization transfer ratio measures in normal-appearing white matter show periventricular gradient abnormalities in multiple sclerosis.

Liu Z; Pardini M; Yaldizli Ö; Sethi V; Muhlert N; Wheeler-Kingshott CA; Samson RS; Miller DH; Chard DT. Brain : a journal of neurology. 2015.

Motor network efficiency and disability in multiple sclerosis.

Pardini M; Yaldizli Ö; Sethi V; Muhlert N; Liu Z; Samson RS; Altmann DR; Ron MA; Wheeler-Kingshott CA; Miller DH; Chard DT. Neurology. 2015.

The relationship of a multi-parameter MRI measure of motor network efficiency with disability in multiple sclerosis

Pardini,M; Yaldizli,O; Sethi,V; Muhlert,N; Liu,Z; Samson,RS; Altmann,DR; Ron,MA; Wheeler-Kingshott,CAM; Miller,DHM; Chard,DT. . 2015.

Isolated cognitive relapses in multiple sclerosis.

Pardini M; Uccelli A; Grafman J; Yaldizli Ö; Mancardi G; Roccatagliata L. Journal of neurology, neurosurgery, and psychiatry. 2014.

Isolated cognitive relapses in multiple sclerosis.

Pardini M; Uccelli A; Grafman J; Yaldizli Ö; Mancardi G; Roccatagliata L. Journal of neurology, neurosurgery, and psychiatry. 2014.

Lesion-to-ventricle distance and other risk factors for the persistence of newly formed black holes in relapsing-remitting multiple sclerosis.

Papadopoulou A; Menegola M; Kuhle J; Ramagopalan SV; D'Souza M; Sprenger T; Radue EW; Kappos L; Yaldizli Ö. Multiple sclerosis (Houndmills, Basingstoke, England). 2014.

MRI characteristics of periaqueductal lesions in multiple sclerosis.

Papadopoulou A; Naegelin Y; Weier K; Amann M; Hirsch J; von Felten S; Yaldizli O; Sprenger T; Radue EW; Kappos L; Gass A. Multiple sclerosis and related disorders. 2014.

Multiple sclerosis registries in Europe - results of a systematic survey.

Flachenecker P; Buckow K; Pugliatti M; Kes VB; Battaglia MA; Boyko A; Confavreux C; Ellenberger D; Eskic D; Ford D; Friede T; Fuge J; Glaser A; Hillert J; Holloway E; Ioannidou E; Kappos L; Kasilingam E; Koch-Henriksen N; Kuhle J; Lepore V; Middleton R; Myhr KM; Orologas A; Otero S; Pitschnau-Michel D; Rienhoff O; Sastre-Garriga J; Schyns-Liharska T; Sutovic D; Thalheim C; Trojano M; Vlasov YV; Yaldizli O; EUReMS Consortium.. Multiple sclerosis (Houndmills, Basingstoke, England). 2014.

Network Efficiency As A Final Common Pathway For Cognitive Deficits In Multiple Sclerosis: A Single Network Graph Theory Study.

Pardini,M; Sethi,V; Muhlert,N; Yaldizli,O; Palesi,F; Altmann,D; Ron,M; Wheeler-Kingshott,CAM; Miller,DH; Chard,DT. . 2014.

The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients.

Yaldizli Ö; Penner IK; Frontzek K; Naegelin Y; Amann M; Papadopoulou A; Sprenger T; Kuhle J; Calabrese P; Radü EW; Kappos L; Gass A. Multiple sclerosis (Houndmills, Basingstoke, England). 2014.

[Not Available].

Hafner P; Yaldizli O; Baumann T. Therapeutische Umschau. Revue therapeutique. 2013.

Balance control in multiple sclerosis: correlations of trunk sway during stance and gait tests with disease severity.

Corporaal SH; Gensicke H; Kuhle J; Kappos L; Allum JH; Yaldizli Ö. Gait & posture. 2013.

Influence of Disease Severity on Fatigue in Patients with Parkinson's Disease Is Mainly Mediated by Symptoms of Depression

van Dijk, Jitse P.; Havlikova, Eva; Rosenberger, Jaroslav; Nagyova, Iveta; Skorvanek, Matej; Gdovinova, Zuzana; Lok, Willem; Groothoff, Johan W.; Middel, Berrie. EUROPEAN NEUROLOGY. 2013.

Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis.

Kuhle J; Malmeström C; Axelsson M; Plattner K; Yaldizli O; Derfuss T; Giovannoni G; Kappos L; Lycke J. ACTA NEUROLOGICA SCANDINAVICA. 2013.

Resident corner 2012: Multiple sclerosis

Yaldizli,O; Kuhle,J; Derfuss,T; Sprenger,T; Kappos,L. . 2013.

Schwindel aus neurologischer Sicht unter spezieller Berücksichtigung von Notfallsituationen

Hafner,Patricia; Yaldizli,Özgür; Baumann,Thomas. Therapeutische Umschau. Revue therapeutique. 2013.

Theory of mind deficits in patients with multiple sclerosis – a separate entity of socio-cognitive impairment?

Zwahlen,D; Schaub,S; Yaldizli,O; Opwis,K; Annoni,JM; Kappos,L; Penner,IK. . 2013.

Immunmodulierende Basistherapie nach dem ersten Schub einer möglichen Multiple Sklerose

Yaldizli,O. . 2012.

Immunomodulatory treatment of multiple sclerosis in Switzerland – a nationwide follow-up of 8046 patients

Lienert,C; Schoetzau,A; Beer,S; Kappos,L; Yaldizli,O. . 2012.

Monoclonal antibodies and recombinant immunoglobulins for the treatment of multiple sclerosis.

Gensicke H; Leppert D; Yaldizli Ö; Lindberg RL; Mehling M; Kappos L; Kuhle J. CNS DRUGS. 2012.

Olfactory bulb volume and neuropsychological performance, fatigue severity and depression in multiple sclerosis patients

Yonekawa,T; Penner,IK; Naegelin,Y; Kuhle,J; Stippich,C; Radue,EWR; Kappos,L; Sprenger,T; Yaldizli,O. . 2012.

Screening for balance disorders in mildly affected multiple sclerosis patients.

Fanchamps MH; Gensicke H; Kuhle J; Kappos L; Allum JH; Yaldizli O. Journal of Neurology. 2012.

Fatigue and progression of corpus callosum atrophy in multiple sclerosis.

Yaldizli Ö; Glassl S; Sturm D; Papadopoulou A; Gass A; Tettenborn B; Putzki N. Journal of Neurology. 2011.

Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS.

Kuhle J; Gosert R; Bühler R; Derfuss T; Sutter R; Yaldizli O; Radue EW; Ryschkewitsch C; Major EO; Kappos L; Frank S; Hirsch HH. Neurology. 2011.

Resident corner 2011: Multiple sclerosis

Yaldizli,O; Kuhle,J; Derfuss,T; Sprenger,T; Kappos,L. . 2011.

Bildgebung bei MS: MRT für Diagnose, Verlaufskontrolle und Therapieplanung

Yaldizli,O; Naumann,N; Ahlhelm,F; Gass,A. . 2010.

Corpus callosum index and long-term disability in multiple sclerosis patients.

Yaldizli O; Atefy R; Gass A; Sturm D; Glassl S; Tettenborn B; Putzki N. Journal of Neurology. 2010.

Dimethyl fumarate for multiple sclerosis.

Papadopoulou A; D'Souza M; Kappos L; Yaldizli O. EXPERT OPINION ON INVESTIGATIONAL DRUGS. 2010.

Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries.

Putzki N; Yaldizli O; Mäurer M; Cursiefen S; Kuckert S; Klawe C; Maschke M; Tettenborn B; Limmroth V. European journal of neurology. 2010.

Emerging oral treatments in multiple sclerosis - clinical utility of cladribine tablets.

Gasperini C; Ruggieri S; Pozzilli C. Therapeutics and Clinical Risk Management. 2010.

Magnetic resonance imaging predictors of the persistence of T1 black holes in multiple sclerosis patients

Menegola,M; Papadopoulou,A; Traud,S; Gass,A; Kappos,L; Radue,EW; Yaldizli,O. . 2010.

Natalizumab reduces clinical and MRI activity in multiple sclerosis patients with high disease activity: results from a multicenter study in Switzerland.

Putzki N; Yaldizli O; Bühler R; Schwegler G; Curtius D; Tettenborn B. EUROPEAN NEUROLOGY. 2010.

Regional corpus callosum atrophy, cognitive dysfunction and fatigue in multiple sclerosis patients

Yaldizli,O; Penner,IK; Frontzek,K; Madoerin,P; Naegelin,Y; Schaellebaum,M; Amann,M; Papadopoulou,A; Calabrese,P; Radue,EW; Kappos,L; Gass,A. . 2010.

Risk factors for suicide attempts in patients with alcohol dependence or abuse and a history of depressive symptoms: a subgroup analysis from the WHO/ISBRA study.

Yaldizli O; Kuhl HC; Graf M; Wiesbeck GA; Wurst FM. DRUG ALCOHOL REV. 2010.

[After lymph node biopsy. Pain and weakness in the right shoulder].

Yaldizli O; Tettenborn B. MMW Fortschr Med. 2009.

[Natalizumab and atypical naevi: Comments on the pharmacovigilance note by J.-L. Schmutz et al].

Yaldizli O; Baumberger P; Putzki N. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE. 2009.

Fatigue bei MS

Yaldizli,O; Tettenborn,B; Putzki,N. . 2009.

Fatigue is not associated with impaired function of regulatory T cells in untreated patients with multiple sclerosis.

Yaldizli O; Kumar M; Vago S; Kreuzfelder E; Limmroth V; Putzki N. EUROPEAN NEUROLOGY. 2009.

Innovative orale Therapien der schubförmigen Multiplen Sklerose

Yaldizli,O; Tettenborn,B; Putzki,N. . 2009.

Multiple sclerosis associated fatigue during natalizumab treatment.

Putzki N; Yaldizli O; Tettenborn B; Diener HC. Journal of the neurological sciences. 2009.

Natalizumab disproportionally increases circulating B cells and decreases the frequency of natural T regulatory cells.

Putzki,N; Yaldizli,O; Tettenborn,B; Kreuzfelder,E. . 2009.

Natalizumab in the treatment of multiple sclerosis.

Yaldizli O; Putzki N. Therapeutic advances in neurological disorders. 2009.

Natalizumab reduces clinical and MRI disesase activity in second line treatment of relapsing-remitting multiple sclerosis: results of a multi-center study.

Putzki,N; Yaldizli,O; Mäurer,M; Kuckert,S; Cursiefen,S; Tettenborn,B; Limmroth,V. . 2009.

Pain in the sole of the foot. Have you suspected its cause in the knee?

Yaldizli,Özgür; Coco,Oracio; Hundsberger,Thomas; Tettenborn,Barbara. MMW Fortschr Med. 2009.

Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis.

Putzki N; Pfriem A; Limmroth V; Yaldizli O; Tettenborn B; Diener HC; Katsarava Z. European journal of neurology. 2009.

Substantia nigra hyperechogenicity and CSF dopamine depletion in HIV.

Obermann M; Küper M; Kastrup O; Yaldizli O; Esser S; Thiermann J; Koutsilieri E; Arendt G; Diener HC; Maschke M; German Competence Network HIV/AIDS.. Journal of Neurology. 2009.

Substantia nigra hyperechogenicity and CSF dopamine depletion in HIV.

Obermann M; Küper M; Kastrup O; Yaldizli O; Esser S; Thiermann J; Koutsilieri E; Arendt G; Diener HC; Maschke M; German Competence Network HIV/AIDS.. Journal of Neurology. 2009.

T regulatory cell function is impaired in relapsing remitting but not in primary progressive multiple sclerosis.

Yaldizli,O; Kamou,R; Tettenborn,B; Putzki,N. . 2009.

T regulatory cell function is impaired in relapsing-remitting but not in primary progressive multiple sclerosis.

Yaldizli,O; Kamou,R; Putzki,N. . 2009.

An unusual complication of a successful cardiopulmonary reanimation.

Yaldizli O; Muroi C; Keller E. AMERICAN JOURNAL OF EMERGENCY MEDICINE. 2008.

Increased basal-ganglia activation performing a non-dystonia-related task in focal dystonia.

Obermann M; Yaldizli O; de Greiff A; Konczak J; Lachenmayer ML; Tumczak F; Buhl AR; Putzki N; Vollmer-Haase J; Gizewski ER; Diener HC; Maschke M. European journal of neurology. 2008.

Neurosurgical site infections in patients treated with long-term hypothermia and barbiturate coma after subarachnoid haemorrhage and early clipping.

Yaldizli,O; Seule,M; Muroi,C; Fortunati,M; Keller,E. . 2008.

Pre-auricular mass. Pseudoaneurysm of the superficial temporal artery.

Yaldizli O; Muroi C; Keller E; Valavanis A. NEW ZEAL MED J. 2008.

Spontaneous spinal subarachnoid haemorrhage--a complication of alcohol withdrawal therapy.

Yaldizli O; Euler S; Willi B; Wiesbeck GA; Wurst FM. DRUG ALCOHOL REV. 2008.

Thromboembolieprophylaxe

Keller,E; Yaldizli,O; Bombeli,T. . 2008.

Tobacco smoking and depression--results from the WHO/ISBRA study.

Wiesbeck GA; Kuhl HC; Yaldizli O; Wurst FM; WHO/ISBRA Study Group on Biological State and Trait Markers of Alcohol Use and Dependence.. NEUROPSYCHOBIOLOGY. 2008.

Morphometric changes of sensorimotor structures in focal dystonia.

Obermann M; Yaldizli O; De Greiff A; Lachenmayer ML; Buhl AR; Tumczak F; Gizewski ER; Diener HC; Maschke M. MOVEMENT DISORDERS. 2007.

Morphometric changes of sensorimotor structures in focal dystonia.

Obermann M; Yaldizli O; De Greiff A; Lachenmayer ML; Buhl AR; Tumczak F; Gizewski ER; Diener HC; Maschke M. MOVEMENT DISORDERS. 2007.

Altered cortical activation of patients with blepharospasm during repetitive forearm contraction: a fMRI study.

Obermann,M; Yaldizli,O; De Greiff,A; Lachenmayer,ML; Tumsczak,F; Buhl,AR; Vollmer-Haase,J; Gizewski,ER; Diener,HC; Maschke,M. . 2006.

Carotid intima-media thickness in HIV-infected individuals: relationship of premature atherosclerosis to neuropsychological deficits?

Yaldizli O; Kastrup O; Obermann M; Esser S; Wilhelm H; Ley C; Diener HC; Maschke M. EUROPEAN NEUROLOGY. 2006.

Copper deficiency myelopathy induced by repetitive parenteral zinc supplementation during chronic hemodialysis.

Yaldizli O; Johansson U; Gizewski ER; Maschke M. Journal of Neurology. 2006.

Ethylsulfat: Ein direkter Ethanolmetabolit zum Nachweis kürzlichen Alkoholismus.

Wurst,FM; Dresen,S; Allen,JP; Müller,S; Yaldizli,O; Petitjean,S; Wiesbeck,G; Weinmann,W. . 2006.

Monoclonal antibodies improve therapy of relapsing multiple sclerosis: Molecular mechanisms and clinical results of anti-VLA4 therapy (Natalizumab)

Yaldizli,O; Kappos,L. Springer Medizin Verlag Heidelberg. 2006.

Multiple cerebral metastases mimicking Wernicke's encephalopathy in a chronic alcoholic.

Yaldizli O; Wurst FM; Euler S; Willi B; Wiesbeck G. ALCOHOL AND ALCOHOLISM. 2006.

Pain related potentials by electrical stimulation of skin for detection of small-fiber neuropathy in HIV.

Katsarava Z; Yaldizli O; Voulkoudis C; Diener HC; Kaube H; Maschke M. Journal of Neurology. 2006.

Risikofaktoren für einen Suizidversuch bei alkoholabhängigen Patienten mit einer vorangehenden depressiven Episode – eine Subgruppenanalyse der WHO / ISBRA – Studie.

Yaldizli,O; Graf,M; Wiesbeck,G; Wurst,FM. . 2006.

Transcranial sonography of the third ventricle and cognitive dysfunction in HIV patients.

Yaldizli O; Kastrup O; Obermann M; Esser S; Wilhelm H; Ley C; Forsting M; Maschke M. Journal of Neurology. 2006.

Veränderte kortikale Aktivierung fokaler Dystonie Patienten bei repetetiven Unterarmbewegungen – eine fMRI – Studie.

Yaldizli,O; Obermann,M; De Greiff,A; Lachenmayer,ML; Tumczak,F; Buhl,AR; Vollmer-Haase,J; Gizewski,ER; Diener,HC; Maschke,M. . 2006.

Basal ganglia infarction mimicking glioblastoma.

Yaldizli O; Kastrup O; Wanke I; Maschke M. EUROPEAN JOURNAL OF MEDICAL RESEARCH. 2005.

Korreliert eine erhöhte Intima Media Dicke der A. carotis communis mit neuropsychologischen Defiziten bei HIV-Patienten?

Yaldizli,O; Kastrup,O; Ley,C; Wilhelm,H; Esser,S; Diener,HC; Maschke,M. . 2005.

Pain-evoked cortical potentials: A new method in the diagnosis of the small – fiber – neuropathy in HIV-positive patients.

Yaldizli,O; Katsarava,Z; Voulkoudis,C; Kaube,H; Esser,S; Diener,HC; Maschke,M. . 2005.

Korreliert die duplexsonographisch bestimmte Weite des III. Ventrikels mit Beeinträchtigungen kognitiver Funktionen bei Patienten mit HIV-Erkrankung?

Yaldizli,O; Ley,C; Esser,S; Diener,HC; Maschke,M. . 2004.

Schmerz-Evozierte Potentiale: Eine neue Methode in der Diagnostik der small-fiber neuropathy bei HIV-positiven Patienten.

Katsarava,Z; Yaldizli,O; Voulkoudis,C; Esser,S; Diener,HC; Kaube,H; Maschke,M. . 2004.

Symptomzuordnung nach Gefässgebieten

Pfefferkorn,T; Yaldizli,O. . 2004.

The course of an unclear focal myotonic disorder. Video-Talk.

Weber,R; Yaldizli,O; Kastrup,O; Diener,HC; Busch,E. . 2002.